Presence of predictive markers of type I prediabetes mellitus in first degree relatives of type I diabetes mellitus;Presencia de marcadores predictivos del estado de prediabetes mellitus tipo I en familiares de pacientes con diabetes mellitus tipo I

Medicina Clinica

Volumn 107, Issue 10, 1996, Pages 371-374

  Rodriguez Villar C ^a   Conget, I ^a   Esmatjes, E ^a   Levy, I ^a   Calvet, J ^b   Figuerola, D ^b   Bergua, M ^c   Gutierrez A ^d   Miralles, J ^e   Millan M ^b   Peig, M ^b   Gomis, R ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Servicio de Endocrinologíe   (Spain)

^c Centro de Asistencia Primaria   (Spain)

^d Centro Hospitalario   (Spain)

^e HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; CLINICAL TRIAL; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MULTICENTER STUDY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADULT; ANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0030604828     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Goday A, Castell C, Tresserras R, Canela J, Taberner JL, Lloveras G and the Catalan Epidemiology Diabetes Study Group. Incidence of type 1 (insulin-dependent) diabetes mellitus in Catalonia, Spain. Diabetologia 1992; 35: 267-271.
2. Espinosa C, Hart W, Rovira J y la colaboración de Química Farmacéutica Bayer. El coste de la incidencia de la diabetes mellitus tipo I en España. Endocrinologia 1995; 42 (Supl 1): 22.
3. Palmer JP, Asplin CM, Clemons P, Lyon K, Iatpati O, Raghu P et al. Insulin antibodies of insulin dependent diabetics before insulin treatment. Science 1983; 222: 1.337-1.339.
4. Vardi P, Ziegler AG, Mathews JH, Dib S, Keller RJ, Ricker AT et al. Concentration of insulin antibodies at onset of type I diabetes: inverse log-linear correlation with age. Diabetes Care 1988; 11: 736-739.
5. Lendrum R, Walker JG, Gamble DR. Islet cell anbibodies in juvenile diabetes mellitus of recent onset. Lancet 1975; 1: 880-882.
6. Bonifacio E, Bingley P, Shattock M, Dean BM, Dunger D, Gale E et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147-149.
7. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludivgsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human islet proteins. Nature (Lond) 1982; 298: 167-169.
8. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ. 64.000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 1990; 335: 1.357-1.360.
9. Deaizpurua HJ, Harrison LC, Cram DS. An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes 1992; 41: 1.182-1.187.
10. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. Frist-degree relatives of patients with type I diabetes mellitus: islet cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313: 461-464.
11. Srikanta S, Ganda OP, Jackson RA, Gleason RE, Kaldany A, Garovoy MR et al. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med 1986; 99: 320-326.
12. Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo FG, Evidence for a long prediabetic period in type I (insulin dependent) diabetes mellitus. Lancet 1981; 2: 1.363-1.364.
13. Ziegler AG, Herbowitz RD, Jackson RA, Soelner JS, Eisenbarth GS. Predicting type diabetes. Diabetes Care 1990; 13: 762-765.
14. Proyecto Cooperativo Multicéntrico de la Sociedad Española de Diabetes (SED) sobre prediabetes tipo I. Avances en Diabetologia 1992; 5 (Supl 2): 57-65.
15. Eisenbarth GS, Verge CF, Allen H, Rewers MJ. The design of trials for prevention of IDDM. Diabetes 1993; 42: 941-947.
16. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1.279-1.283.
17. Vardi P, Dib SA, Tuttleman M, Connelly JE, Grinbergs M, Radizabeh A et al. Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 1987; 35: 1.286-1.291.
18. Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series 727. Ginebra: World Health Organization, 1985.
19. Kuglin B, Bertrams J, Linke C, Gries FA, Kolb H. Prevalence of cytoplasmatic islet cell antibodies and insulin antibodies is increased in subjects with genetically defined high risk for insulin dependent diabetes mellitus. Klin Wochenschr 1989; 67: 66-73.
20. Fernández-Álvarez J, Tomás C, Usac E, Rodríguez C. The ICA-IgG: problems in determination, Endccrinologia 1992; 39 (Supl 2): 13-19.
21. Riley WJ, MacLaren NK, Krischer J, Spillar RP, Silvertein JH, Schatz DA et al. A prospective study of the development of diabetes in relatives of patients with insulin dependent diabetes. N Engl J Med 1990; 323: 1.167-1.172.
22. Ziegler AG, Baumgartl HJ, Standl E, Mehnert H. Risk of progression to Diabetes of low titer ICA-positive first-degree relatives of type I diabetes in Southern Germany. J Autoimmun 1990; 3: 619-624.
23. McCullogh DK, Klaff U, Kahn SE, Scoenfeld SL, Greenbaum CJ, Mauseth RS. Nonprogression of subclinical B-cell dysfunction among first-degree relatives of IDDM patients. Diabetes 1990; 39: 549-556.
24. Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EAM et al. Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia 1986; 29: 339-342.
25. Roll U, Christie MR, Standl E, Ziegler AG. Associations of anti-gad antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetics patients. Diabetes 1994; 43: 154-160.
26. Thivolet CH, Tappaz M, Durand A, Peterson J, Stefanutti A, Chatelain P et al. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type I (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 1992; 35: 570-576.
27. Schmidli RS, Colman PG, Bonifacio E and participating Laboratories. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb Workshop. Diabetes 1995; 44: 636-640.
28. Vardi P, Crisa L, Jackson RA and coauthors. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type I (insulin-dependent) diabetic patients. Diabetologia 1991; 34: 93-102.
29. Lorenzen T, Pociot F, Hougaard P, Nerup J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia 1994; 37: 321-327.
30. Wagener DK, Sacks JM, LaPorte R, MacGregor JM. The Pittsburgh Study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 1982; 31: 136-144.